Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Serotonin dynamics in and around the central nervous system: is autism solvable without fundamental insights?

Janušonis S.

Int J Dev Neurosci. 2014 Dec;39:9-15. doi: 10.1016/j.ijdevneu.2014.05.009. Epub 2014 Jun 2. Review.

PMID:
24886833
2.

Ontogeny of brain and blood serotonin levels in 5-HT receptor knockout mice: potential relevance to the neurobiology of autism.

Janusonis S, Anderson GM, Shifrovich I, Rakic P.

J Neurochem. 2006 Nov;99(3):1019-31. Epub 2006 Sep 18.

3.

Origin of the blood hyperserotonemia of autism.

Janusonis S.

Theor Biol Med Model. 2008 May 22;5:10. doi: 10.1186/1742-4682-5-10.

4.
5.

Serotonergic paradoxes of autism replicated in a simple mathematical model.

Janusonis S.

Med Hypotheses. 2005;64(4):742-50.

PMID:
15694691
6.

Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.

Anderson GM, Gutknecht L, Cohen DJ, Brailly-Tabard S, Cohen JH, Ferrari P, Roubertoux PL, Tordjman S.

Mol Psychiatry. 2002;7(8):831-6.

7.

Brain growth trajectories in mouse strains with central and peripheral serotonin differences: relevance to autism models.

Flood ZC, Engel DL, Simon CC, Negherbon KR, Murphy LJ, Tamavimok W, Anderson GM, Janušonis S.

Neuroscience. 2012 May 17;210:286-95. doi: 10.1016/j.neuroscience.2012.03.010. Epub 2012 Mar 20.

PMID:
22450231
8.

Platelet and intestinal 5-HT2A receptor mRNA in autistic spectrum disorders - results of a pilot study.

Kazek B, Huzarska M, Grzybowska-Chlebowczyk U, Kajor M, Ciupińska-Kajor M, Woś H, Marszał E.

Acta Neurobiol Exp (Wars). 2010;70(2):232-8. Erratum in: Acta Neurobiol Exp (Wars). 2010;70(4):468.

9.
10.

Platelet SERT as a peripheral biomarker of serotonergic neurotransmission in the central nervous system.

Yubero-Lahoz S, Robledo P, Farré M, de laTorre R.

Curr Med Chem. 2013;20(11):1382-96. Review.

PMID:
23409709
11.

Low platelet-poor plasma levels of serotonin in adult autistic patients.

Spivak B, Golubchik P, Mozes T, Vered Y, Nechmad A, Weizman A, Strous RD.

Neuropsychobiology. 2004;50(2):157-60.

PMID:
15292671
12.
13.

[Metabolism of serotonin in autism in children].

Bursztejn C, Ferrari P, Dreux C, Braconnier A, Lancrenon S.

Encephale. 1988 Nov-Dec;14(6):413-9. Review. French.

PMID:
3068046
14.
15.

The developmental disruptions of serotonin signaling may involved in autism during early brain development.

Yang CJ, Tan HP, Du YJ.

Neuroscience. 2014 May 16;267:1-10. doi: 10.1016/j.neuroscience.2014.02.021. Epub 2014 Feb 27. Review.

PMID:
24583042
16.

Uptake and loss of 14 C-dopamine by platelets from children with infantile autism.

Boullin DJ, O'Brien RA.

J Autism Child Schizophr. 1972 Jan-Mar;2(1):67-74. No abstract available.

PMID:
5067402
18.

Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder.

Cook EH Jr, Arora RC, Anderson GM, Berry-Kravis EM, Yan SY, Yeoh HC, Sklena PJ, Charak DA, Leventhal BL.

Life Sci. 1993;52(25):2005-15.

PMID:
7684805
19.

Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism.

Coutinho AM, Oliveira G, Morgadinho T, Fesel C, Macedo TR, Bento C, Marques C, Ataíde A, Miguel T, Borges L, Vicente AM.

Mol Psychiatry. 2004 Mar;9(3):264-71.

PMID:
15094787
20.

Autism: review of neurochemical investigation.

Cook EH.

Synapse. 1990;6(3):292-308. Review.

PMID:
1700486

Supplemental Content

Support Center